Eyenovia, Inc.

Ticker EYEN

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

11-50 Employees
Based in New York City, New York

Eyenovia, Inc. (NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP鈩�) therapeutics. Eyenovia鈥檚 pipeline is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis.

REPORT RATINGS

4.8 / 5.0 (185)

Eyenovia, Inc. reports have an aggregate usefulness score of 4.8 based on 185 reviews.

Eyenovia, Inc.